Monograph
R01AD01 - Beclometasone |
Not porphyrinogenic |
NP |
Rationale
Inducer of CYP 3A5. Probably no significant systemic exposure. Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Antiinflammatory halogenated glucocorticoide for local (nasal spray) treatment of allergic and vasomotor rhinitis. Low probability for systemic effects. EPI-list: safe. French list: authorized. South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncans Diseases of Metabolism. Philadelphia, WB Saunders, 1980, p939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe
IPNet drug reports
Uneventful use reported in 6 patients with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
United Kingdom
Denmark
Poland
Luxembourg
Finland
Latvia
Serbia© NAPOS 2024